Answers are grounded in this paper and cite their sources.
Shows enhanced disease tolerance in transgenic lettuce, highlighting its potential for commercial agriculture.
Fungal pathogens cause severe yield losses in lettuce production worldwide. We developed transgenic lettuce lines overexpressing the ch5B chitinase gene from Phaseolus vulgaris (bean) under the regulation of the rbcS1 (ribulose-1,5-bisphosphate carboxylase small subunit) promoter. Molecular characterization confirmed stable transgene integration and expression across the selected lines. In vitro assays demonstrated that transgenic leaf extracts significantly inhibited Rhizoctonia solani mycelial growth. Furthermore, inoculation assays in both seedlings and adult plants in the greenhouse showed a significant reduction in lesion areas compared to non-transgenic (NT) controls. Finally, two lines were evaluated in field trials, both showing agronomic substantial equivalence to the NT, satisfying international biosafety frameworks for commercial development. Among them, the ch5B 3-4 line appears to be the most promising candidate for further studies, as it showed slightly higher fresh weight compared to the NT under field conditions.:
No takes yet. Share an insight, caveat, or question.
Radonic et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: